Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations

The treatment of metastatic colorectal cancer (mCRC) harboring BRAF V600 mutations is challenging. These tumors are often refractory to standard treatment. Therefore, the patients may exhibit rapid clinical deterioration, depriving them of the chance to receive salvage therapy. In newly diagnosed pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanat, Ozkan, Ertas, Hulya, Caner, Burcu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579731/
https://www.ncbi.nlm.nih.gov/pubmed/33133378
http://dx.doi.org/10.4251/wjgo.v12.i10.1080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579731/
https://www.ncbi.nlm.nih.gov/pubmed/33133378
http://dx.doi.org/10.4251/wjgo.v12.i10.1080

Ejemplares similares